During the past decade, Avance Trials conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Avance Trials" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Avance Trials" are "Atopic Dermatitis" (3 trials), "Chronic Spontaneous Urticaria" (1 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Avance Trials" in a lesser frequency.

Most popular intervention types in "Avance Trials" are "Drug" (3 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lebrikizumab" (3 trials), "Placebo" (3 trials), "Apremilast (CC-10004)" (1 trials), "Omalizumab" (1 trials) and "Tezepelumab Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Avance Trials" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Avance Trials". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Avance Trials, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Avance Trials, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".